Novel targets for sepsis‐induced kidney injury: the glomerular arterioles and the sympathetic nervous system

Sepsis and septic shock are the most common causes of acute kidney injury (AKI) in the intensive care unit, and mortality remains high despite improvements in our ability to support vital organs. The lack of development of effective treatments is partly because there has been little advance in our understanding of the pathophysiology of septic AKI, owing to the difficulty in conducting experiments on critically ill patients and use of inappropriate experimental models. Recently, however, a number of new concepts have emerged that challenge existing dogma and give insights into the causes of AKI. Traditionally, renal ischaemia has been proposed as the main cause of AKI, but it is becoming apparent that in sepsis with a hyperdynamic circulation, the most common situation in septic patients, there is an increase or at least no decrease in renal blood flow. In this review, the possible role of changes in pre‐ and postglomerular resistance in setting the increased level of renal blood flow in the presence of a decreased glomerular filtration rate is discussed. New evidence also indicates that the increased sympathetic nerve activity that occurs in sepsis may contribute to the induction of organ failure. Experimental studies indicate that inhibition of central sympathetic outflow with α2‐adrenoceptor agonists or treatment with β1‐adrenoceptor antagonists might reduce mortality in experimental endotoxaemia and sepsis. The possibility that these beneficial actions are partly dependent on a reduction in the excessive cytokine release caused by marked and prolonged sympathetic activation is discussed.

[1]  R. Bellomo,et al.  Effect of selective inhibition of renal inducible nitric oxide synthase on renal blood flow and function in experimental hyperdynamic sepsis* , 2012, Critical care medicine.

[2]  François M Abboud,et al.  Autonomic Neural Regulation of the Immune System: Implications for Hypertension and Cardiovascular Disease , 2012, Hypertension.

[3]  R. Bellomo,et al.  The Effects of Terlipressin on Regional Hemodynamics and Kidney Function in Experimental Hyperdynamic Sepsis , 2012, PloS one.

[4]  G. Pell,et al.  Renal bioenergetics during early gram-negative mammalian sepsis and angiotensin II infusion , 2012, Intensive Care Medicine.

[5]  A. Jacob,et al.  Ghrelin-mediated sympathoinhibition and suppression of inflammation in sepsis. , 2012, American journal of physiology. Endocrinology and metabolism.

[6]  J. Chvojka,et al.  Searching for mechanisms that matter in early septic acute kidney injury: an experimental study , 2011, Critical care.

[7]  Can Ince,et al.  The Microcirculation as a Therapeutic Target in the Treatment of Sepsis and Shock , 2011, Seminars in respiratory and critical care medicine.

[8]  M. Sugimachi,et al.  Centrally administered ghrelin activates cardiac vagal nerve in anesthetized rabbits , 2011, Autonomic Neuroscience.

[9]  M. Rundgren,et al.  Toll-like receptor 4 inhibitor TAK-242 attenuates acute kidney injury in endotoxemic sheep. , 2011, Anesthesiology.

[10]  R. Bellomo,et al.  The impact of intrarenal nitric oxide synthase inhibition on renal blood flow and function in mild and severe hyperdynamic sepsis* , 2011, Critical care medicine.

[11]  A. Géloën,et al.  Alpha-2 agonists to reduce vasopressor requirements in septic shock? , 2010, Medical hypotheses.

[12]  A. Geloen,et al.  Increased pressor response to noradrenaline during septic shock following clonidine? , 2010, Anaesthesia and intensive care.

[13]  Tsuyoshi Mori,et al.  Septic acute renal failure. , 2010, Contributions to nephrology.

[14]  M. Dünser,et al.  How to protect the heart in septic shock: a hypothesis on the pathophysiology and treatment of septic heart failure. , 2010, Medical hypotheses.

[15]  M. Singer,et al.  Cardioprotection, attenuated systemic inflammation, and survival benefit of &bgr;1-adrenoceptor blockade in severe sepsis in rats* , 2010, Critical care medicine.

[16]  J. Cavaillon,et al.  Resilience to bacterial infection: difference between species could be due to proteins in serum. , 2010, The Journal of infectious diseases.

[17]  R. Bellomo,et al.  Angiotensin II in experimental hyperdynamic sepsis , 2009, Critical care.

[18]  R. Bellomo,et al.  Septic shock induces distinct changes in sympathetic nerve activity to the heart and kidney in conscious sheep. , 2009, American journal of physiology. Regulatory, integrative and comparative physiology.

[19]  M. Bucher,et al.  INHIBITION OF NF-&kgr;B ACTIVITY PREVENTS DOWNREGULATION OF &agr;1-ADRENERGIC RECEPTORS AND CIRCULATORY FAILURE DURING CLP-INDUCED SEPSIS , 2009, Shock.

[20]  Martin W Dünser,et al.  Sympathetic Overstimulation During Critical Illness: Adverse Effects of Adrenergic Stress , 2009, Journal of intensive care medicine.

[21]  C. Coopersmith,et al.  The sepsis seesaw: tilting toward immunosuppression , 2009, Nature Medicine.

[22]  B. Funke,et al.  Central sympatholytics prolong survival in experimental sepsis , 2009, Critical care.

[23]  Smitha Yerrum,et al.  beta2 Adrenoreceptor blockade attenuates the hyperinflammatory response induced by traumatic injury. , 2009, Surgery.

[24]  P. Radermacher,et al.  Renal haemodynamic, microcirculatory, metabolic and histopathological responses to peritonitis-induced septic shock in pigs , 2008, Critical care.

[25]  N. Nakagawa,et al.  EXPERIMENTAL MODELS OF SEPSIS AND THEIR CLINICAL RELEVANCE , 2008, Shock.

[26]  R. Bellomo,et al.  Early acute kidney injury and sepsis: a multicentre evaluation , 2008, Critical care.

[27]  A. A. Romanovsky,et al.  Fever response to intravenous prostaglandin E2 is mediated by the brain but does not require afferent vagal signaling. , 2008, American journal of physiology. Regulatory, integrative and comparative physiology.

[28]  R. Bellomo,et al.  The histopathology of septic acute kidney injury: a systematic review , 2008, Critical care.

[29]  A. Guillouzo,et al.  Catecholamines induce an inflammatory response in human hepatocytes , 2008, Critical care medicine.

[30]  T. Ravikumar,et al.  Ghrelin attenuates sepsis-induced acute lung injury and mortality in rats. , 2007, American journal of respiratory and critical care medicine.

[31]  A. Cauwels Nitric oxide in shock. , 2007, Kidney international.

[32]  D. Nance,et al.  Autonomic innervation and regulation of the immune system (1987–2007) , 2007, Brain, Behavior, and Immunity.

[33]  R. Bellomo,et al.  Renal blood flow and function during recovery from experimental septic acute kidney injury , 2007, Intensive Care Medicine.

[34]  R. Bassel-Duby,et al.  Role of interleukin-6 in cardiac inflammation and dysfunction after burn complicated by sepsis. , 2007, American journal of physiology. Heart and circulatory physiology.

[35]  M. Schedlowski,et al.  beta-Adrenergic blockade during systemic inflammation: impact on cellular immune functions and survival in a murine model of sepsis. , 2007, Resuscitation.

[36]  D. Rittirsch,et al.  The disconnect between animal models of sepsis and human sepsis , 2007, Journal of leukocyte biology.

[37]  R. Bellomo,et al.  Renal Vascular Resistance in Sepsis , 2006, Nephron Physiology.

[38]  R. Bellomo,et al.  Effect of Low-Dose Vasopressin Infusion on Vital Organ Blood Flow in the Conscious Normal and Septic Sheep , 2006, Anaesthesia and intensive care.

[39]  T. Ravikumar,et al.  Ghrelin inhibits sympathetic nervous activity in sepsis. , 2006, American journal of physiology. Endocrinology and metabolism.

[40]  R. Bellomo,et al.  Renal blood flow in experimental septic acute renal failure. , 2006, Kidney international.

[41]  Didier Payen,et al.  Does dopamine administration in shock influence outcome? Results of the Sepsis Occurrence in Acutely Ill Patients (SOAP) Study* , 2006, Critical care medicine.

[42]  W. Abelmann,et al.  Propranolol ameliorates and epinephrine exacerbates progression of acute and chronic viral myocarditis. , 2005, American journal of physiology. Heart and circulatory physiology.

[43]  Ping Wang,et al.  Sympathetic excitotoxicity in sepsis: pro-inflammatory priming of macrophages by norepinephrine. , 2005, Frontiers in bioscience : a journal and virtual library.

[44]  C. Vayssettes-Courchay,et al.  Sympathetic activation and tachycardia in lipopolysaccharide treated rats are temporally correlated and unrelated to the baroreflex , 2005, Autonomic Neuroscience.

[45]  R. Bellomo,et al.  Renal blood flow in sepsis , 2005, Critical care.

[46]  F. Haddy,et al.  Acute renal failure and sepsis. , 2004, The New England journal of medicine.

[47]  K. Denton,et al.  Predominant postglomerular vascular resistance response to reflex renal sympathetic nerve activation during ANG II clamp in rabbits. , 2004, American journal of physiology. Regulatory, integrative and comparative physiology.

[48]  Y. Takemoto,et al.  Effects of dexmedetomidine on mortality rate and inflammatory responses to endotoxin-induced shock in rats , 2004, Critical care medicine.

[49]  C. Esmon,et al.  Why do animal models (sometimes) fail to mimic human sepsis? , 2004, Critical care medicine.

[50]  F. Coluzzi,et al.  Effects of terlipressin on systemic and regional haemodynamics in catecholamine-treated hyperkinetic septic shock , 2004, Intensive Care Medicine.

[51]  J. Bakker,et al.  Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: Effect on survival in patients with septic shock* , 2004, Critical care medicine.

[52]  R. Bellomo,et al.  Vital organ blood flow during hyperdynamic sepsis. , 2003, Chest.

[53]  R. Bellomo,et al.  Norepinephrine and vital organ blood flow during experimental hyperdynamic sepsis , 2003, Intensive Care Medicine.

[54]  Mitchell M. Levy,et al.  2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference , 2003, Intensive Care Medicine.

[55]  D. Chittock,et al.  Beneficial Effects of Short-term Vasopressin Infusion during Severe Septic Shock , 2002, Anesthesiology.

[56]  R. Weiss,et al.  Central mineralocorticoid receptor blockade improves volume regulation and reduces sympathetic drive in heart failure. , 2001, American journal of physiology. Heart and circulatory physiology.

[57]  D. Chinkes,et al.  Reversal of catabolism by beta-blockade after severe burns. , 2001, The New England journal of medicine.

[58]  G. Clermont,et al.  Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care , 2001, Critical care medicine.

[59]  H. Baba,et al.  Cardiac remodeling after long term norepinephrine treatment in rats. , 2001, Cardiovascular research.

[60]  R. Bellomo,et al.  Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial , 2000, The Lancet.

[61]  K. Denton,et al.  Effects of angiotensin II on regional afferent and efferent arteriole dimensions and the glomerular pole. , 2000, American journal of physiology. Regulatory, integrative and comparative physiology.

[62]  K. Giercksky,et al.  Nitric oxide indices in human septic shock , 2000, Critical care medicine.

[63]  C. Liang,et al.  Alterations by norepinephrine of cardiac sympathetic nerve terminal function and myocardial beta-adrenergic receptor sensitivity in the ferret: normalization by antioxidant vitamins. , 2000, Circulation.

[64]  M. Kim,et al.  The Effect of Clonidine Pretreatment on the Perioperative Proinflammatory Cytokines, Cortisol, and ACTH Responses in Patients Undergoing Total Abdominal Hysterectomy , 2000, Anesthesia and analgesia.

[65]  P. Sipkema,et al.  Interaction of oxyradicals, antioxidants, and nitric oxide during sepsis , 2000, Critical care medicine.

[66]  K. Tracey,et al.  Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin , 2000, Nature.

[67]  D. Annane,et al.  Compartmentalised inducible nitric-oxide synthase activity in septic shock , 2000, The Lancet.

[68]  I. Chaudry,et al.  Kupffer cells are responsible for producing inflammatory cytokines and hepatocellular dysfunction during early sepsis. , 1999, The Journal of surgical research.

[69]  C. Saper,et al.  Mechanisms of CNS response to systemic immune challenge: the febrile response , 1997, Trends in Neurosciences.

[70]  D. Nance,et al.  Peripheral endotoxin increases splenic sympathetic nerve activity via central prostaglandin synthesis. , 1997, The American journal of physiology.

[71]  G. Jennings,et al.  Adverse consequences of high sympathetic nervous activity in the failing human heart. , 1995, Journal of the American College of Cardiology.

[72]  R. Landmann,et al.  Beta-adrenergic receptors in human leukocyte subpopulations. , 1992, European journal of clinical investigation.

[73]  K. Denton,et al.  Morphometric analysis of the actions of angiotensin II on renal arterioles and glomeruli. , 1992, The American journal of physiology.

[74]  J. Parrillo,et al.  Detection of renal blood flow abnormalities in septic and critically ill patients using a newly designed indwelling thermodilution renal vein catheter. , 1990, Chest.

[75]  K. Demarest,et al.  Comparison of intracerebroventricular and intracarotid infusions of PGE2 in conscious sheep. , 1989, The American journal of physiology.

[76]  S. Lundin,et al.  Changes in renal sympathetic nerve activity during experimental septic and endotoxin shock in conscious rats. , 1988, Circulatory shock.

[77]  M. Iriki,et al.  Renal and cutaneous vasomotor and respiratory rate adjustments to peripheral cold and warm stimuli and to bacterial endotoxin in conscious rabbits. , 1982, Journal of the autonomic nervous system.

[78]  C. Lucas,et al.  Sepsis: a mechanism for vasodilatation in the kidney. , 1973, Annals of surgery.

[79]  R. Meek,et al.  Plasma Catechofamines in Patients with Serious Postoperative Infection , 1973, Annals of surgery.

[80]  C. Lucas,et al.  Altered renal homeostasis with acute sepsis. Clinical significance. , 1973, Archives of surgery.

[81]  A. W. den Hartog,et al.  Open Access RESEARCH , 2010 .

[82]  鈴木 武志 Infusion of the β-adrenergic blocker esmolol attenuates myocardial dysfunction in septic rats , 2006 .

[83]  D. Breimer,et al.  Pharmacological investigations on lipopolysaccharide-induced permeability changes in the blood-brain barrier in vitro. , 2003, Microvascular research.

[84]  J. Berk,et al.  The treatment of shock with beta adrenergic blockade. , 1972, Archives of surgery.